Find a story
Search Spins
Search titles, summaries, and missing voices across published articles — press releases, announcements, and media coverage.
5 results for “biopharma”
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc. - IMMX
A law firm has launched a preliminary investigation into potential investor claims against Immix Biopharma, a biopharmaceutical company trading on NASDAQ, following possible securities law violations — an event with no AI or technology relevance despite its placement in an AI technology feed.
Aug 7, 2026
Lipocine Appoints Michael J. Grissinger to Board of Directors
Lipocine Inc., a biopharmaceutical company focused on oral drug delivery, appointed Michael J. Grissinger to its Board of Directors.
Aug 3, 2026
Unpacking Anthropic's 100-day sprint into biopharma: Nobel hires, M&A and major ambition - Endpoints News
Anthropic launched a 100-day strategic push into biopharma, hiring Nobel laureates and pursuing M&A to position itself as an AI partner for drug discovery — signaling expansion beyond core AI safety and infrastructure.
Jul 21, 2026
Strategic Collaboration | Sanyou Bio and Baiyunshan Xihe Join Forces to Advance Innovative Radiopharmaceuticals and Radiodiagnostics
Two Chinese pharmaceutical companies announced a strategic cooperation agreement to advance radiopharmaceuticals and radiodiagnostics, with no operational details, timelines, or deliverables disclosed.
Published Jul 4, 2026 · Analyzed Jul 6, 2026
Updated: Anthropic launches Claude Science as a product for biopharma, starts own drug programs - Endpoints News
Anthropic has launched Claude Science, a specialized AI product for biopharmaceutical R&D, and initiated internal drug discovery programs — signaling expansion beyond AI infrastructure into therapeutic development.
Published Jun 30, 2026 · Analyzed Jul 5, 2026